Skip to content


  • Erratum
  • Open Access

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

  • 1,
  • 1,
  • 1,
  • 2,
  • 2, 3, 4,
  • 1, 2,
  • 1, 2,
  • 5,
  • 6,
  • 7,
  • 1, 8,
  • 1, 2, 8,
  • 1, 2,
  • 1, 2,
  • 1 and
  • 1, 9Email author
Experimental Hematology & Oncology20165:10

  • Received: 30 March 2016
  • Accepted: 30 March 2016
  • Published:

The original article was published in Experimental Hematology & Oncology 2016 5:7

Erratum to: Exp Hematol Oncol (2016) 5:7 DOI 10.1186/s40164-016-0036-3

Unfortunately, the original version of this article [1] contained an error. The author Caroline Dartigeas’ name was inverted. The correct presentation is as noted here, Caroline Dartigeas. There will be an update to amend this as well as this erratum.



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

INSERM UMR1098, Établissement Français du Sang Bourgogne Franche Comté, Université de Franche-Comté, SFR FED4234, 25020 Besançon, France
EA3181 et Service de Dermatologie, Université de Franche Comté, CHU de Besançon, Besançon, France
CHRU, Department of Rheumatology, Université de Franche-Comté EA 4266, INSERM CIC-1431, 25000 Besançon, France
EA 4266, Université de Franche-Comté, Besançon, France
Inserm U1037, Université Toulouse 3-ERL CNRS, CHU Purpan, Toulouse, France
Hématologie Clinique, CHU Estaing, 1 Place Lucie Aubrac, 63003 Clermont-Ferrand Cedex 1, France
Hematologie, CHU Bretonneau, Tours, France
Hematology Department, CHU Jean Minjoz, 25020 Besançon, France
Laboratoire de Thérapeutique Immuno-Moléculaire et cellulaire des cancers, INSERM UMR1098, Etablissement Français du Sang–Bourgogne/Franche-Comté, 8, rue du Docteur Jean-François-Xavier Girod, 25020 Besançon Cedex, France


  1. Gamonet C, Bole-Richard E, Delherme A, Aubin F, Toussirot E, Garnache-Ottou F, Godet Y, Ysebaert L, Tournilhac O, Dartigeas C, Larosa F, Deconinck E, Saas P, Borg C, Deschamps M, Ferrand C. New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies. Exp Hematol Oncol. 2016;5:7.View ArticlePubMedPubMed CentralGoogle Scholar